INTRODUCTIONDuring infancy, humoral rejection of a cardiac allograft has not been reported in the absence of risk factors. We report an infant with dilated cardiomyopathy who developed multiple episodes of acute humoral rejection after heart transplantation in the absence of risk factors such as prior transplantation, blood transfusions, ventricular assist devices, and elevation of panel reactive antibodies. We had parental permission as well as approval by the Institutional Review Board to study all patients undergoing heart transplantation at our institution.PATIENT PROFILEA 4‐month‐old previously healthy male presented with heart failure symptoms. An echocardiogram revealed severely depressed left ventricular (LV) function (ejection fraction of 8%), moderate pericardial effusion, and severe LV dilation. He was placed on milrinone and furosemide infusions and was diagnosed with a dilated cardiomyopathy, and listed for cardiac transplantation. He had never received a blood transfusion prior to his transplant. Pretransplant panel reactive antibodies I and II were 0%, at the age of 4 months and the night before transplant. At the age of 7 months, he underwent an ABO‐compatible (O+/O+), cytomegalovirus‐ and Epstein‐Barr virus‐mismatched (CMV+/−, EBV+/−) bicaval heart transplant. The prospective donor‐specific crossmatch was negative. The surgery was uneventful with an allograft ischemic time of 104 min. The
Journal of Cardiac Surgery – Wiley
Published: Jan 1, 2018
Keywords: ; ;
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera